MIGLITOL Side Effects

6759317-8 | Hepatocellular Injury, In-stent Coronary Artery Restenosis
on Jan 25, 2010 Female patient from JAPAN , 67 years of age, weighting 89.29 lb, was diagnosed with diabetes mellitus, hypertension, angina pectoris, percutaneous coronary intervention and was treated with Miglitol (View Usage). Patient experienced the following unwanted or unexpected effects: hepatocellular injury, in-stent coronary artery restenosis. Miglitol dosage: 50 Mg, 3x/day. During the same period patient was treated with NORVASC (5 Mg, 2x/day) (View Norvasc Review and Norvasc Label ), ALDACTONE (25 Mg, Unk) (View Aldactone Review and Aldactone Label ), CLOPIDOGREL BISULFATE (75 Mg, Unk) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), AMARYL (1 Mg, Unk) (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6712234-1 | Hepatocellular Injury, In-stent Coronary Artery Restenosis
Patient was taking Miglitol (View Usage). Patient had the following side effects: hepatocellular injury, in-stent coronary artery restenosis on Apr 23, 2010 from JAPAN Additional patient health information: Female patient , 67 years of age, weighting 89.29 lb, was diagnosed with diabetes mellitus, hypertension, angina pectoris, percutaneous coronary intervention and. Miglitol dosage: 50 Mg, 3x/day. During the same period patient was treated with NORVASC (5 Mg, 2x/day) (View Norvasc Review and Norvasc Label ), ALDACTONE (Unk) (View Aldactone Review and Aldactone Label ), CLOPIDOGREL BISULFATE (75 Mg, Unk) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (Unk Mg, Unk) (View Aspirin Review and Aspirin Label ), AMARYL (Unk Mg, Unk) (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6664545-6 | In-stent Coronary Artery Restenosis, Liver Disorder
Adverse event was reported on Jan 25, 2010 by a Female patient taking Miglitol (View Usage) (Dosage: 50 Mg, 3x/day) was diagnosed with diabetes mellitus, hypertension, angina pectoris, percutaneous coronary intervention, gastritis prophylaxis and. Location: JAPAN , 67 years of age, weighting 89.29 lb, After Miglitol was administered, patient had the following side effects: in-stent coronary artery restenosis, liver disorder. During the same period patient was treated with NORVASC (5 Mg, 2x/day) (View Norvasc Review and Norvasc Label ), ALDACTONE (Unk) (View Aldactone Review and Aldactone Label ), CLOPIDOGREL BISULFATE (Unk) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (Unk Mg, Unk) (View Aspirin Review and Aspirin Label ), AMARYL (Unk Mg, Unk) (View Amaryl Review and Amaryl Label ), LANSOPRAZOLE (Unk) (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6539854-1 | In-stent Coronary Artery Restenosis, Liver Function Test Abnormal
on Dec 07, 2009 Female patient from JAPAN , 67 years of age, weighting 89.29 lb, was diagnosed with diabetes mellitus, hypertension, angina pectoris, percutaneous coronary intervention, gastritis prophylaxis and was treated with Miglitol (View Usage). Patient experienced the following unwanted or unexpected effects: in-stent coronary artery restenosis, liver function test abnormal. Miglitol dosage: 50 Mg, 3x/day. During the same period patient was treated with NORVASC (5 Mg, 2x/day) (View Norvasc Review and Norvasc Label ), ALDACTONE (Unk Mg, Unk) (View Aldactone Review and Aldactone Label ), CLOPIDOGREL BISULFATE (Unk Mg, Unk) (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (Unk Mg, Unk) (View Aspirin Review and Aspirin Label ), AMARYL (Unk Mg, Unk) (View Amaryl Review and Amaryl Label ), TAKEPRON (Unk) (View Takepron Review and Takepron Label ). Patient was hospitalized.


6520900-6 | Abdominal Distension, Abdominal Pain, Nausea, Subileus
on Dec 17, 2009 Male patient from JAPAN , 76 years of age, was diagnosed with diabetes mellitus, hepatic cirrhosis, duodenal ulcer and was treated with Miglitol (View Usage). Patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), nausea (What is nausea?), subileus. Miglitol dosage: Unk. During the same period patient was treated with STRONG NEO MINOPHAGEN C (40 Ml, Unk) (View Strong Neo-minophagen C Review and Strong Neo-minophagen C Label ), OMEPRAL (20 Mg, Unk) (View Omepral Review and Omepral Label ), INSULIN HUMAN (Unk) (View Insulin Human Review and Insulin Human Label ), SODIUM ALGINATE (30 Ml, Unk) (View Sodium Alginate Review and Sodium Alginate Label ). Patient was hospitalized.

6520871-2 | Coronary Artery Restenosis, Liver Function Test Abnormal
Patient was taking Miglitol (View Usage). After Miglitol was administered, patient had the following side effects: coronary artery restenosis, liver function test abnormal on Dec 17, 2009 from JAPAN Additional patient health information: Female patient , 67 years of age, was diagnosed with diabetes mellitus, hypertension, gastritis prophylaxis, angina pectoris, percutaneous coronary intervention and. Miglitol dosage: 50 Mg, 3x/day. During the same period patient was treated with ALDACTONE (25 Mg, Daily) (View Aldactone Review and Aldactone Label ), NORVASC (2.5 Mg, Daily) (View Norvasc Review and Norvasc Label ), TAKEPRON (15 Mg, Daily) (View Takepron Review and Takepron Label ), CLOPIDOGREL SULFATE (300 Mg, Unk) (View Clopidogrel Sulfate Review and Clopidogrel Sulfate Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), AMARYL (1 Mg, Daily) (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6519669-0 | Device Occlusion, Liver Function Test Abnormal
Adverse event was reported on Dec 17, 2009 by a Female patient taking Miglitol (View Usage) (Dosage: 50 Mg, 3x/day) was diagnosed with diabetes mellitus, hypertension, angina pectoris, percutaneous coronary intervention, gastritis prophylaxis and. Location: JAPAN , 67 years of age, Patient experienced the following unwanted or unexpected effects: device occlusion, liver function test abnormal. During the same period patient was treated with NORVASC (5 Mg, 2x/day) (View Norvasc Review and Norvasc Label ), ALDACTONE (Unk Mg, Unk) (View Aldactone Review and Aldactone Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ), ASPIRIN (Unk Mg, Unk) (View Aspirin Review and Aspirin Label ), AMARYL (Unk Mg, Unk) (View Amaryl Review and Amaryl Label ), TAKEPRON (15 Unk, Unk) (View Takepron Review and Takepron Label ). Patient was hospitalized.

6505604-8 | Abdominal Distension, Abdominal Pain, Nausea, Subileus
on Dec 08, 2009 Male patient from JAPAN , 76 years of age, was diagnosed with diabetes mellitus and was treated with Miglitol (View Usage). Patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), nausea (What is nausea?), subileus. Miglitol dosage: Unk. During the same period patient was treated with STRONG NEO MINOPHAGEN C (40 Ml, Unk) (View Strong Neo-minophagen C Review and Strong Neo-minophagen C Label ), OMEPRAL (20 Mg, Unk) (View Omepral Review and Omepral Label ), INSULIN HUMAN (View Insulin Human Review and Insulin Human Label ). Patient was hospitalized.

6504075-5 | Hepatocellular Injury, Liver Function Test Abnormal
on Dec 07, 2009 Female patient from JAPAN , 67 years of age, was diagnosed with diabetes mellitus, hypertension, angina pectoris, gastritis prophylaxis and was treated with Miglitol (View Usage). After Miglitol was administered, patient had the following side effects: hepatocellular injury, liver function test abnormal. Miglitol dosage: Unk Mg, Unk. During the same period patient was treated with NORVASC (Unk Mg, Unk) (View Norvasc Review and Norvasc Label ), ALDACTONE (Unk Mg, Unk) (View Aldactone Review and Aldactone Label ), PLAVIX (Unk Mg, Unk) (View Plavix Review and Plavix Label ), ASPIRIN (Unk Mg, Unk) (View Aspirin Review and Aspirin Label ), AMARYL (Unk Mg, Unk) (View Amaryl Review and Amaryl Label ), TAKEPRON (Unk Mg, Unk) (View Takepron Review and Takepron Label ), MICARDIS (Unk Mg, Unk) (View Micardis Review and Micardis Label ), COVERSYL (Unk Mg, Unk) (View Coversyl Review and Coversyl Label ). Patient was hospitalized.

6493551-X | Cholestasis, Hepatic Function Abnormal
Patient was taking Miglitol (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, hepatic function abnormal on Dec 01, 2009 from JAPAN Additional patient health information: Female patient , 88 years of age, was diagnosed with type 2 diabetes mellitus and. Miglitol dosage: Unk. During the same period patient was treated with MICARDIS (Unk) (View Micardis Review and Micardis Label ).

6491345-2 | Hepatic Function Abnormal
Adverse event was reported on Dec 01, 2009 by a Female patient taking Miglitol (View Usage) (Dosage: Unk) was diagnosed with type 2 diabetes mellitus and. Location: JAPAN , 88 years of age, Patient had the following side effects: hepatic function abnormal. During the same period patient was treated with MICARDIS (Unk) (View Micardis Review and Micardis Label ).

6464569-8 | Abdominal Distension, Abdominal Pain, Ileus Paralytic, Nausea
on Nov 19, 2009 Male patient from JAPAN , 76 years of age, was diagnosed with diabetes mellitus and was treated with Miglitol (View Usage). After Miglitol was administered, patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), ileus paralytic, nausea (What is nausea?). Miglitol dosage: Unk Mg, Unk. During the same period patient was treated with STRONG NEO MINOPHAGEN C (40 Ml, Unk) (View Strong Neo-minophagen C Review and Strong Neo-minophagen C Label ), OMEPRAL (20 Mg, Unk) (View Omepral Review and Omepral Label ), INSULIN HUMAN (View Insulin Human Review and Insulin Human Label ). Patient was hospitalized.

6453884-X | Hepatic Function Abnormal, Liver Function Test Abnormal
on Nov 17, 2009 Male patient from JAPAN , 71 years of age, was diagnosed with type 2 diabetes mellitus, constipation (What is constipation?), urethritis and was treated with Miglitol (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, liver function test abnormal. Miglitol dosage: 150 Mg, Unk. During the same period patient was treated with GLUCOBAY (300 Mg, Unk) (View Glucobay Review and Glucobay Label ), GASMOTIN (15 Mg, Unk) (View Gasmotin Review and Gasmotin Label ), MITIGLINIDE (15 Mg, Unk) (View Mitiglinide Review and Mitiglinide Label ), MAGNESIUM OXIDE (990 Mg, Unk) (View Magnesium Oxide Review and Magnesium Oxide Label ), MINOPEN (100 Mg, Unk) (View Minopen Review and Minopen Label ). Patient was hospitalized.

6423691-2 | Hepatic Function Abnormal
Patient was taking Miglitol (View Usage). Patient had the following side effects: hepatic function abnormal on Oct 20, 2009 from JAPAN Additional patient health information: Female patient , 57 years of age, was diagnosed with diabetes mellitus, atrial fibrillation (What is atrial fibrillation?), hyperlipidaemia, hypertension, gastritis, congestive cardiomyopathy and. Miglitol dosage: Unk Mg, Unk. During the same period patient was treated with ASPIRIN (Unk Mg, Unk) (View Aspirin Review and Aspirin Label ), LOCHOL (Unk) (View Lochol Review and Lochol Label ), LUPRAC (4 Mg, Unk) (View Luprac Review and Luprac Label ), LANSOPRAZOLE (15 Mg, Unk) (View Lansoprazole Review and Lansoprazole Label ), DIOVAN (160 Mg, Unk) (View Diovan Review and Diovan Label ), CALBLOCK (16 Mg, Unk) (View Calblock Review and Calblock Label ), WARFARIN (1 Mg, Unk) (View Warfarin Review and Warfarin Label ), ARTIST (1.25 Mg, Unk) (View Artist Review and Artist Label ). Patient was hospitalized.

6419997-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal
Adverse event was reported on Oct 14, 2009 by a Female patient taking Miglitol (View Usage) (Dosage: Unk) was diagnosed with type 2 diabetes mellitus, anaemia, post procedural infection, vascular graft, blood pressure management, prophylaxis and. Location: JAPAN , 54 years of age, After Miglitol was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal. During the same period patient was treated with FERROMIA (Unk) (View Ferromia Review and Ferromia Label ), CRAVIT (400 Mg, Unk) (View Cravit Review and Cravit Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), LASIX (40 Mg, Unk) (View Lasix Review and Lasix Label ), ALDACTONE (25 Mg, Unk) (View Aldactone Review and Aldactone Label ), SIGMART (15 Mg, Unk) (View Sigmart Review and Sigmart Label ), OMEPRAL (20 Mg, Unk) (View Omepral Review and Omepral Label ), CINAL (400 Mg, Unk) (View Cinal Review and Cinal Label ). Patient was hospitalized.

6412053-X | Hepatic Function Abnormal, Liver Function Test Abnormal
on Oct 14, 2009 Female patient from JAPAN , 71 years of age, was diagnosed with type 2 diabetes mellitus, constipation (What is constipation?), urethritis and was treated with Miglitol (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, liver function test abnormal. Miglitol dosage: 150 Mg, Unk. During the same period patient was treated with GLUCOBAY (300 Mg, Unk) (View Glucobay Review and Glucobay Label ), GASMOTIN (15 Mg, Unk) (View Gasmotin Review and Gasmotin Label ), MITIGLINIDE (15 Mg, Unk) (View Mitiglinide Review and Mitiglinide Label ), MAGNESIUM OXIDE (990 Mg, Unk) (View Magnesium Oxide Review and Magnesium Oxide Label ), MINOPEN (100 Mg, Unk) (View Minopen Review and Minopen Label ). Patient was hospitalized.

6400529-0 | Hepatic Function Abnormal, Liver Function Test Abnormal
on Oct 06, 2009 Female patient from JAPAN , 71 years of age, was diagnosed with type 2 diabetes mellitus, constipation (What is constipation?), urethritis and was treated with Miglitol (View Usage). Patient had the following side effects: hepatic function abnormal, liver function test abnormal. Miglitol dosage: 150 Mg, Unk. During the same period patient was treated with GLUCOBAY (300 Mg, Unk) (View Glucobay Review and Glucobay Label ), GASMOTIN (15 Mg, Unk) (View Gasmotin Review and Gasmotin Label ), MITIGLINIDE (15 Mg, Unk) (View Mitiglinide Review and Mitiglinide Label ), MAGNESIUM OXIDE (990 Mg, Unk) (View Magnesium Oxide Review and Magnesium Oxide Label ), MINOPEN (100 Mg, Unk) (View Minopen Review and Minopen Label ). Patient was hospitalized.

6394975-1 | Hepatic Function Abnormal
Patient was taking Miglitol (View Usage). After Miglitol was administered, patient had the following side effects: hepatic function abnormal on Sep 29, 2009 from JAPAN Additional patient health information: Female patient , 57 years of age, was diagnosed with diabetes mellitus, hypertension, gastritis, atrial fibrillation (What is atrial fibrillation?), congestive cardiomyopathy, nephrotic syndrome and. Miglitol dosage: Unk Mg, Unk. During the same period patient was treated with LUPRAC (4 Mg, Unk) (View Luprac Review and Luprac Label ), TAKEPRON (15 Mg, Unk) (View Takepron Review and Takepron Label ), DIOVAN (160 Mg, Unk) (View Diovan Review and Diovan Label ), CALBLOCK (16 Mg, Unk) (View Calblock Review and Calblock Label ), WARFARIN (1 Mg, Unk) (View Warfarin Review and Warfarin Label ), ARTIST (1.25 Mg, Unk) (View Artist Review and Artist Label ), PREDONINE (5 Mg, Unk) (View Predonine Review and Predonine Label ), PL (Unk) (View Pl Review and Pl Label ). Patient was hospitalized.

6394117-2 | Pneumatosis Intestinalis
Adverse event was reported on Sep 28, 2009 by a Female patient taking Miglitol (View Usage) (Dosage: Unk Mg, Unk) was diagnosed with type 2 diabetes mellitus, cerebrovascular accident prophylaxis, prophylaxis against gastrointestinal ulcer, hypertension, rhinitis allergic and. Location: JAPAN , 69 years of age, Patient experienced the following unwanted or unexpected effects: pneumatosis intestinalis. During the same period patient was treated with WARFARIN (2 Mg, Unk) (View Warfarin Review and Warfarin Label ), PLETAL (200 Mg, Unk) (View Pletal Review and Pletal Label ), TAKEPRON (15 Mg, Unk) (View Takepron Review and Takepron Label ), NU LOTAN (50 Mg, Unk) (View Nu Lotan Review and Nu Lotan Label ), NORVASC (5 Mg, Unk) (View Norvasc Review and Norvasc Label ), ALLELOCK (10 Mg, Unk) (View Allelock Review and Allelock Label ). Patient was hospitalized.

6393996-2 | Hepatic Function Abnormal, Liver Function Test Abnormal
on Sep 25, 2009 Female patient from JAPAN , 71 years of age, was diagnosed with type 2 diabetes mellitus, constipation (What is constipation?), urethritis and was treated with Miglitol (View Usage). Patient had the following side effects: hepatic function abnormal, liver function test abnormal. Miglitol dosage: Unk Mg, Unk. During the same period patient was treated with GLUCOBAY (Unk Mg, Unk) (View Glucobay Review and Glucobay Label ), GASMOTIN (Dose: 15mg) (View Gasmotin Review and Gasmotin Label ), MITIGLINIDE (Dose: 15mg) (View Mitiglinide Review and Mitiglinide Label ), MAGNESIUM OXIDE (Dose: 990mg) (View Magnesium Oxide Review and Magnesium Oxide Label ), MINOPEN (Dose: 100mg) (View Minopen Review and Minopen Label ). Patient was hospitalized.

6386893-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal
on Jul 28, 2009 Female patient from JAPAN , 83 years of age, was diagnosed with diabetes mellitus and was treated with Miglitol (View Usage). After Miglitol was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic function abnormal. Miglitol dosage: 150mg Daily. During the same period patient was treated with LANTUS (Unk) (View Lantus Review and Lantus Label ), ADALAT CC (Unk) (View Adalat Cc Review and Adalat Cc Label ), THYRADIN (Unk) (View Thyradin Review and Thyradin Label ), PRAVASTATIN SODIUM (Unk) (View Pravastatin Sodium Review and Pravastatin Sodium Label ).

6382940-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal
Patient was taking Miglitol (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal on Aug 28, 2009 from JAPAN Additional patient health information: Female patient , 54 years of age, was diagnosed with type 2 diabetes mellitus, anaemia, post procedural infection, vascular graft, blood pressure management, prophylaxis and. Miglitol dosage: Unk Mg, Unk. During the same period patient was treated with FERROMIA (Unk Mg, Unk) (View Ferromia Review and Ferromia Label ), LEVOFLOXACIN (400 Mg, Unk) (View Levofloxacin Review and Levofloxacin Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), LASIX (40 Mg, Unk) (View Lasix Review and Lasix Label ), ALDACTONE (25 Mg, Unk) (View Aldactone Review and Aldactone Label ), SIGMART (15 Mg, Unk) (View Sigmart Review and Sigmart Label ), OMEPRAL (20 Mg, Unk) (View Omepral Review and Omepral Label ), CINAL (400 Mg, Unk) (View Cinal Review and Cinal Label ). Patient was hospitalized.

6377719-9 | Dizziness, Syncope
Adverse event was reported on Aug 28, 2009 by a Female patient taking Miglitol (View Usage) (Dosage: Unk Mg, Unk) was diagnosed with diabetes mellitus, hypertension, hyperlipidaemia and. Location: JAPAN , 81 years of age, Patient had the following side effects: dizziness (What is dizziness?), syncope. During the same period patient was treated with NORVASC (2.5 Mg, Unk) (View Norvasc Review and Norvasc Label ), CRESTOR (2.5 Mg, Unk) (View Crestor Review and Crestor Label ), RENIVACE (10 Mg, Unk) (View Renivace Review and Renivace Label ), AMARYL (Unk) (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6371053-9 | Liver Disorder
on Sep 10, 2009 Female patient from JAPAN , 57 years of age, was diagnosed with diabetes mellitus and was treated with Miglitol (View Usage). After Miglitol was administered, patient had the following side effects: liver disorder. Miglitol dosage: Unk Mg, Unk. During the same period patient was treated with LUPRAC (4 Mg, Unk) (View Luprac Review and Luprac Label ), TAKEPRON (15 Mg, Unk) (View Takepron Review and Takepron Label ), DIOVAN (160 Mg, Unk) (View Diovan Review and Diovan Label ), CALBLOCK (16 Mg, Unk) (View Calblock Review and Calblock Label ), WARFARIN (1 Mg, Unk) (View Warfarin Review and Warfarin Label ), ARTIST (1.25 Mg, Unk) (View Artist Review and Artist Label ), PREDONINE (5 Mg, Unk) (View Predonine Review and Predonine Label ), PL (Unk) (View Pl Review and Pl Label ). Patient was hospitalized.

6367304-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal
on Jun 09, 2009 Female patient from JAPAN , 83 years of age, was treated with Miglitol (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic function abnormal. Miglitol dosage: 150 Mg Daily.

6360487-4 | Pneumatosis Intestinalis
Patient was taking Miglitol (View Usage). Patient had the following side effects: pneumatosis intestinalis on Sep 02, 2009 from JAPAN Additional patient health information: Female patient , 69 years of age, was diagnosed with type 2 diabetes mellitus, cerebrovascular accident prophylaxis, prophylaxis against gastrointestinal ulcer, hypertension, rhinitis allergic and. Miglitol dosage: Unk Mg, Unk. During the same period patient was treated with WARFARIN (Dose: 2mg) (View Warfarin Review and Warfarin Label ), PLETAL (Dose: 200mg) (View Pletal Review and Pletal Label ), TAKEPRON (Dose: 15mg) (View Takepron Review and Takepron Label ), NU LOTAN (Dose: 50mg) (View Nu Lotan Review and Nu Lotan Label ), NORVASC (Dose: 5mg) (View Norvasc Review and Norvasc Label ), ALLELOCK (Dose: 10mg) (View Allelock Review and Allelock Label ). Patient was hospitalized.

6359955-0 | Hepatic Function Abnormal, Liver Function Test Abnormal
Adverse event was reported on Sep 03, 2009 by a Female patient taking Miglitol (View Usage) (Dosage: Unk Mg, Unk) was diagnosed with type 2 diabetes mellitus, constipation (What is constipation?), urethritis and. Location: JAPAN , 71 years of age, After Miglitol was administered, patient had the following side effects: hepatic function abnormal, liver function test abnormal. During the same period patient was treated with GLUCOBAY (Unk Mg, Unk) (View Glucobay Review and Glucobay Label ), GASMOTIN (Dose: 15mg) (View Gasmotin Review and Gasmotin Label ), MITIGLINIDE (Dose: 15mg) (View Mitiglinide Review and Mitiglinide Label ), MAGNESIUM OXIDE (Dose: 990mg) (View Magnesium Oxide Review and Magnesium Oxide Label ), MINOPEN (Dose: 100mg) (View Minopen Review and Minopen Label ). Patient was hospitalized.

6358607-0 | Leukopenia
on Sep 01, 2009 Female patient from JAPAN , 73 years of age, was diagnosed with diabetes mellitus and was treated with Miglitol (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia. Miglitol dosage: Unk. During the same period patient was treated with METFORMIN HCL (Unk) (View Metformin Hcl Review and Metformin Hcl Label ), AMARYL (Unk) (View Amaryl Review and Amaryl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SERMION (View Sermion Review and Sermion Label ), ARICEPT (View Aricept Review and Aricept Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ). Patient was hospitalized.

6339870-9 | Liver Disorder, Transaminases Increased
on Aug 20, 2009 Female patient from JAPAN , 85 years of age, was diagnosed with diabetes mellitus and was treated with Miglitol (View Usage). Patient had the following side effects: liver disorder, transaminases increased. Miglitol dosage: .

6336736-5 | Dizziness, Syncope
Patient was taking Miglitol (View Usage). After Miglitol was administered, patient had the following side effects: dizziness (What is dizziness?), syncope on Aug 20, 2009 from JAPAN Additional patient health information: Female patient , 80 years of age, was diagnosed with diabetes mellitus and. Miglitol dosage: Unk Mg, Unk. During the same period patient was treated with NORVASC (2.5 Mg, Unk) (View Norvasc Review and Norvasc Label ), CRESTOR (2.5 Mg, Unk) (View Crestor Review and Crestor Label ), RENIVACE (Unk) (View Renivace Review and Renivace Label ), AMARYL (Unk) (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6318420-7 | Leukopenia
Adverse event was reported on Aug 07, 2009 by a Female patient taking Miglitol (View Usage) (Dosage: Unk) was diagnosed with diabetes mellitus and. Location: JAPAN , 73 years of age, Patient experienced the following unwanted or unexpected effects: leukopenia. During the same period patient was treated with METFORMIN HCL (Unk) (View Metformin Hcl Review and Metformin Hcl Label ), AMARYL (Unk) (View Amaryl Review and Amaryl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SERMION (View Sermion Review and Sermion Label ), ARICEPT (View Aricept Review and Aricept Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ). Patient was hospitalized.

6314829-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Function Abnormal
on Aug 06, 2009 Female patient from JAPAN , 47 years of age, was diagnosed with diabetes mellitus, epididymitis, pyrexia, pain (What is pain?), insomnia, constipation (What is constipation?), type 2 diabetes mellitus and was treated with Miglitol (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Miglitol dosage: Unk Mg, Unk. During the same period patient was treated with MEROPEN (View Meropen Review and Meropen Label ), FAROM (Unk) (View Farom Review and Farom Label ), LOXONIN (Unk) (View Loxonin Review and Loxonin Label ), MYSLEE (Unk) (View Myslee Review and Myslee Label ), PURSENNID (Unk) (View Pursennid Review and Pursennid Label ), AMARYL (1 Mg, Unk) (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6310411-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Function Abnormal
on Apr 09, 2009 Female patient from JAPAN , 58 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Miglitol (View Usage). After Miglitol was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Miglitol dosage: 50 Mg, 3x/day. During the same period patient was treated with LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), MITIGLINIDE (Unk) (View Mitiglinide Review and Mitiglinide Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ).

6309217-2 | Hepatic Function Abnormal
Patient was taking Miglitol (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal on Jul 14, 2009 from JAPAN Additional patient health information: Female patient , 49 years of age, was diagnosed with type 2 diabetes mellitus and. Miglitol dosage: 75 Mg, Unk. During the same period patient was treated with ACTOS (7.5 Mg, Unk) (View Actos Review and Actos Label ), METFORMIN HYDROCHLORIDE (750 Mg, Unk) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), AMARYL (6 Mg, Unk) (View Amaryl Review and Amaryl Label ), AMLODIPINE BESILATE (5 Mg, Unk) (View Amlodipine Besilate Review and Amlodipine Besilate Label ), OLMETEC (20 Mg, Unk) (View Olmetec Review and Olmetec Label ).

6308238-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatitis
Adverse event was reported on May 21, 2009 by a Female patient taking Miglitol (View Usage) (Dosage: Unk) was diagnosed with diabetes mellitus, pulmonary tuberculosis and. Location: JAPAN , 65 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatitis (What is hepatitis?). During the same period patient was treated with ISONIAZID (Unk) (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (Unk) (View Rifampicin Review and Rifampicin Label ), AMARYL (Unk) (View Amaryl Review and Amaryl Label ), STREPTOMYCIN (2 Iu Ow, Unk) (View Streptomycin Review and Streptomycin Label ).

6308196-1 | Dehydration, Diarrhoea, Hepatic Function Abnormal
on Jul 30, 2009 Female patient from JAPAN , 35 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Miglitol (View Usage). After Miglitol was administered, patient had the following side effects: dehydration, diarrhoea, hepatic function abnormal. Miglitol dosage: 50 Mg, Alternate Day. During the same period patient was treated with HUMALOG (18 Iu, Unk) (View Humalog Review and Humalog Label ), INSULIN DETEMIR (20 Iu, Unk) (View Insulin Detemir Review and Insulin Detemir Label ), GLYCORAN (750 Mg, Unk) (View Glycoran Review and Glycoran Label ). Patient was hospitalized.

6306849-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Hepatic Enzyme Increased
on May 20, 2009 Female patient from JAPAN , 57 years of age, was diagnosed with diabetes mellitus and was treated with Miglitol (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatic enzyme increased. Miglitol dosage: 50 Mg, 3x/day. During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), LIPITOR (View Lipitor Review and Lipitor Label ), MELBIN (View Melbin Review and Melbin Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), OMEPRAL (View Omepral Review and Omepral Label ), VASOLAN (View Vasolan Review and Vasolan Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ZESULAN (View Zesulan Review and Zesulan Label ).

6302672-3 | Depressed Level Of Consciousness, Hypoglycaemia
Patient was taking Miglitol (View Usage). Patient had the following side effects: depressed level of consciousness, hypoglycaemia on Jul 23, 2009 from FRANCE Additional patient health information: Female patient , 74 years of age, was diagnosed with type 2 diabetes mellitus and. Miglitol dosage: 100 Mg, 3x/day. During the same period patient was treated with DAONIL (5 Mg, 3x/day) (View Daonil Review and Daonil Label ), SINTROM (View Sintrom Review and Sintrom Label ), ALDALIX (50 Mg, Unk) (View Aldalix Review and Aldalix Label ), AVODART (0.5 Mg, Unk) (View Avodart Review and Avodart Label ), BISOPROLOL (10 Mg, Unk) (View Bisoprolol Review and Bisoprolol Label ), LEXOMIL (6 Mg, Unk) (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

6292500-7 | Ileus
Adverse event was reported on Jul 21, 2009 by a Female patient taking Miglitol (View Usage) (Dosage: Unk Mg, Unk) was diagnosed with diabetes mellitus and. Location: JAPAN , 75 years of age, After Miglitol was administered, patient had the following side effects: ileus. During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), PLETAL (View Pletal Review and Pletal Label ), TAKEPRON (View Takepron Review and Takepron Label ), NU LOTAN (View Nu Lotan Review and Nu Lotan Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6291483-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Function Abnormal
on Jul 21, 2009 Female patient from JAPAN , 47 years of age, was diagnosed with diabetes mellitus, type 2 diabetes mellitus and was treated with Miglitol (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Miglitol dosage: Unk Mg, Unk. During the same period patient was treated with AMARYL (1 Mg, Unk) (View Amaryl Review and Amaryl Label ), NOVORAPID (36 Iu, Unk) (View Novorapid Review and Novorapid Label ), LANTUS (14 Iu, Unk) (View Lantus Review and Lantus Label ). Patient was hospitalized.

6288810-X | Hepatic Function Abnormal
on Jul 14, 2009 Female patient from JAPAN , 49 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Miglitol (View Usage). Patient had the following side effects: hepatic function abnormal. Miglitol dosage: Unk Mg, Unk. During the same period patient was treated with ACTOS (Unk Mg, Unk) (View Actos Review and Actos Label ), METFORMIN HYDROCHLORIDE (750 Mg, Unk) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), AMARYL (6 Mg, Unk) (View Amaryl Review and Amaryl Label ), AMLODIPINE BESILATE (5 Mg, Unk) (View Amlodipine Besilate Review and Amlodipine Besilate Label ), OLMETEC (20 Mg, Unk) (View Olmetec Review and Olmetec Label ).

6288808-1 | Hepatic Function Abnormal, Liver Function Test Abnormal
Patient was taking Miglitol (View Usage). After Miglitol was administered, patient had the following side effects: hepatic function abnormal, liver function test abnormal on Jul 14, 2009 from JAPAN Additional patient health information: Female patient , 71 years of age, was diagnosed with diabetes mellitus and. Miglitol dosage: Unk Mg, Unk. During the same period patient was treated with GLUCOBAY (Unk Mg, Unk) (View Glucobay Review and Glucobay Label ), GASMOTIN (Unk Mg, Unk) (View Gasmotin Review and Gasmotin Label ), MITIGLINIDE (View Mitiglinide Review and Mitiglinide Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ).

6288374-0 | Insomnia
Adverse event was reported on Jul 14, 2009 by a Female patient taking Miglitol (View Usage) (Dosage: Unk) was diagnosed with diabetes mellitus and. Location: JAPAN , 71 years of age, Patient experienced the following unwanted or unexpected effects: insomnia. During the same period patient was treated with AMARYL (1 Mg, Unk) (View Amaryl Review and Amaryl Label ), ACTOS (Unk) (View Actos Review and Actos Label ), EUGLUCON (View Euglucon Review and Euglucon Label ). Patient was hospitalized.

6286258-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Function Abnormal
on Mar 27, 2009 Female patient from JAPAN , 58 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Miglitol (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Miglitol dosage: 50 Mg, 3x/day. During the same period patient was treated with LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), MITIGLINIDE (30 Mg, Unk) (View Mitiglinide Review and Mitiglinide Label ), CRESTOR (2.5 Mg, Unk) (View Crestor Review and Crestor Label ).

6285356-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Hepatic Enzyme Increased
on May 20, 2009 Female patient from JAPAN , 57 years of age, was diagnosed with diabetes mellitus and was treated with Miglitol (View Usage). After Miglitol was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatic enzyme increased. Miglitol dosage: 50 Mg, 3x/day. During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), LIPITOR (View Lipitor Review and Lipitor Label ), MELBIN (View Melbin Review and Melbin Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), OMEPRAL (View Omepral Review and Omepral Label ), VASOLAN (View Vasolan Review and Vasolan Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ZESULAN (View Zesulan Review and Zesulan Label ).

6278189-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatitis
Patient was taking Miglitol (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatitis (What is hepatitis?) on May 21, 2009 from JAPAN Additional patient health information: Female patient , 65 years of age, was diagnosed with diabetes mellitus, pulmonary tuberculosis and. Miglitol dosage: Unk. During the same period patient was treated with ISONIAZID (Unk) (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (Unk) (View Rifampicin Review and Rifampicin Label ), AMARYL (Unk) (View Amaryl Review and Amaryl Label ), STREPTOMYCIN (2 Iu Ow, Unk) (View Streptomycin Review and Streptomycin Label ).

6272124-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatitis
Adverse event was reported on May 21, 2009 by a Female patient taking Miglitol (View Usage) (Dosage: 3 Df, Unk) . Location: JAPAN , 65 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatitis (What is hepatitis?).

6269501-8 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased
on Jun 30, 2009 Female patient from JAPAN , 52 years of age, was treated with Miglitol (View Usage). After Miglitol was administered, patient had the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. Miglitol dosage: 100 Mg, Unk.

6269176-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Hepatic Enzyme Increased
on May 15, 2009 Female patient from JAPAN , 57 years of age, was treated with Miglitol (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatic enzyme increased. Miglitol dosage: Unk Mg, Unk.

6267277-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Function Abnormal
Patient was taking Miglitol (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal on Mar 27, 2009 from JAPAN Additional patient health information: Female patient , 58 years of age, . Miglitol dosage: 150 Mg, Unk.